Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
OTX2
REST API REST API
Homo sapiens
OTX2 is differentially expressed in 84 experiments: 37 organism parts: cerebellum, brain, ... (35 more);, 42 disease states: normal, AF, ... (40 more);, 41 cell types 55 cell lines 4 compound treatments and 36 other conditions.
Orthologs Otx2 (Mus musculus)   otx2 (Danio rerio)   Q4H303_CIOIN (Ciona intestinalis)   oc (Drosophila melanogaster)   E1BNP1_BOVIN (Bos taurus)   OTX2_RAT (Rattus norvegicus)   otx2 (Xenopus laevis)   OTX2 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term neuron differentiation, protein binding, eukaryotic initiation factor 4E binding, regulation of transcription, DNA-dependent, cytoplasm, protein complex, transcription, DNA-dependent, protein complex assembly, cell fate specification, cell differentiation, sequence-specific DNA binding, axon guidance, endoderm development, positive regulation of transcription from RNA polymerase II promoter, multicellular organismal development, nucleus, protein heterodimerization activity, growth cone, cell fate commitment, regulation of smoothened signaling pathway, regulation of transcription from RNA polymerase II promoter, positive regulation of transcription, DNA-dependent, organ morphogenesis, central nervous system development, dorsal/ventral pattern formation, positive regulation of embryonic development, somite rostral/caudal axis specification, forebrain development, eye photoreceptor cell fate commitment, anatomical structure development, regulation of fibroblast growth factor receptor signaling pathway, inner ear morphogenesis, neuron fate commitment, primitive streak formation, midbrain development, sequence-specific DNA binding transcription factor activity, positive regulation of gastrulation, RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription, anterior/posterior pattern specification
InterPro Term Homeobox, Otx_TF, Otx_TF_C, Otx2_TF
UniProt Accession P32243, F1T0D1, F1T0D0, F1T0C9
Gene-Disease Assocation PITUITARY HORMONE DEFICIENCY, COMBINED, 6; CPHD6, MICROPHTHALMIA, SYNDROMIC 5; MCOPS5
Search EB-eye ENSG00000165588
Show more properties
Experimental Factors
Organism part

studied in E-MTAB-37, E-AFMX-5, E-GEOD-803, E-GEOD-18105, E-AFMX-6, ... (8 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-20854, E-MTAB-37, E-GEOD-5823, E-GEOD-19639, E-GEOD-6013, ... (8 experiments)

Factor Value U/D Experiments
JVM3
1
E-MTAB-37
OE21
1
E-MTAB-37
P3HR1
1
E-MTAB-37
Met5A
1
E-GEOD-6013
NCIH1838
1
E-MTAB-37
MC116
1
E-MTAB-37
49 more value(s).


Cell type

studied in E-GEOD-18811, E-AFMX-5, E-GEOD-21668, E-GEOD-20033, E-GEOD-18147, ... (17 experiments)

Factor Value U/D Experiments
human embryonic stem cell
3
E-GEOD-20033, E-GEOD-18265, E-GEOD-18147
human foreskin fibroblast
2
E-GEOD-18265, E-GEOD-18147
induced pluripotent stem cell
2
E-GEOD-18147, E-GEOD-18265
LCC
1
1
E-GEOD-19188
lymphocyte
1
E-GEOD-11755
primary T lymphocytes
1
E-GEOD-13909
35 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-19743, E-GEOD-6872, E-GEOD-15960, E-TABM-666, ... (17 experiments)

Factor Value U/D Experiments
cervical carcinoma
1
E-GEOD-5823
monoclonal gammopathy of uncertain significance
1
E-MTAB-372
papillary thyroid carcinoma
1
E-GEOD-3467
idiopathic dilated cardiomyopathy
1
E-GEOD-1145
tumor
1
E-GEOD-19188
synovial sarcoma
1
E-MTAB-37
36 more value(s).


Compound treatment

studied in E-GEOD-3284, E-GEOD-15205

Factor Value U/D Experiments
TGF
1
E-GEOD-15205
bacterial endotoxin
1
1
E-GEOD-3284
TNF
1
E-GEOD-15205
control
10
1
E-GEOD-3284


Age at diagnosis

studied in E-GEOD-3494, E-GEOD-21653

Factor Value U/D Experiments
53
2
1
E-GEOD-21653
29
2
1
E-GEOD-3494


Agent
studied in E-GEOD-19519

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, E-GEOD-16363

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-GEOD-21374, E-GEOD-21589, ... (6 experiments)

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-20033, E-MEXP-2359

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743

Environmental stress
studied in E-GEOD-1643

Estrogen receptor status
studied in E-GEOD-6532

family id
studied in E-GEOD-19519

Genetic modification
studied in E-MEXP-1482, E-GEOD-7578, E-GEOD-17385, E-MEXP-2340, E-MEXP-563 ... (5 experiments)

Genotype
studied in E-GEOD-17347

Growth condition
studied in E-TABM-127, E-MEXP-1741

Histology
studied in E-TABM-234

Individual
studied in E-MTAB-197, E-GEOD-3284, E-MEXP-1243, E-TABM-666, E-GEOD-19519, ... (12 experiments)

Infection
studied in E-GEOD-12108, E-GEOD-12254

Injury
studied in E-GEOD-19743

Lymph node status
studied in E-GEOD-6532

Metastasis
studied in E-GEOD-18105

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

Population
studied in E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-19445, E-GEOD-19246

RNAi
studied in E-GEOD-3485

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-19188

Treatment
studied in E-GEOD-19246

Processing time: 0.562 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM